Illumina (ILMN) return on equity (ROE)

Return on equity · fiscal 2025
31.2%

Illumina (ILMN) earned a return on equity of 31.2% in fiscal 2025 (the year ended December 31, 2025). That is 82.8 percentage points higher than the -51.5% of fiscal 2024. Figures as of 17 Nov 2026, 17:27 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Return on equity, fiscal 2025
31.2%
Change on fiscal 2024
+82.8 pts
Highest on record
31.2%fiscal 2025
Lowest on record
-66.7%fiscal 2022
Fiscal years on record
182008–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Illumina return on equity (ROE), in more detail

Across the 18 fiscal years on record (2008–2025), the highest was 31.2% in fiscal 2025 and the lowest -66.7% in fiscal 2022. The fiscal 2025 figure is higher than in every one of the 17 earlier fiscal years on record, whose median is 10.4%.

History · 18 fiscal years

Return on equity by fiscal year

Illumina return on equity (ROE), year by year

Illumina (ILMN) return on equity (ROE) by fiscal year
Fiscal yearReturn on equityChangeYear ended
202531.2% 82.8 pts up
2024-51.5% 31.3 pts down
2023-20.2% 46.5 pts up
2022-66.7%—
20227.1% 6.9 pts down
202114.0%—
201921.7% 0.3 pts down
201822.0% 4.4 pts down
201726.4%—
201721.1% 3.9 pts down
201625.0%—
201424.2% 16.0 pts up
20138.2% 3.3 pts down
201211.5%—
20128.1% 2.4 pts down
201110.4% 2.1 pts up
20108.4%—
20084.9%—

Change is on the fiscal year before, in percentage points; a dash means that year is not on record. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Return on equity is net income divided by shareholders' equity at the fiscal year-end; it is left blank when equity is negative.

How to read it

It is the profit earned on the owners' capital — above about 15% is strong, though heavy debt or large buybacks can inflate it.

Return on equity at health care companies of similar size

Return on equity of Illumina and comparable companies
CompanyReturn on equityFiscal year
Mettler-Toledo International MTD3519.1%2022
Centene CNC-33.4%2025
Genmab GMAB16.5%2025
Illumina ILMN31.2%2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on ILMN

Illumina, figure by figure

Illumina (ILMN) overview: price, valuation and scorecardAll health care companies by market value

Illumina return on equity (ROE): questions and answers

What is Illumina's return on equity?

Illumina (ILMN) earned a return on equity of 31.2% in fiscal 2025 (the year ended December 31, 2025). That is 82.8 percentage points higher than the -51.5% of fiscal 2024.

Is Illumina's return on equity high or low compared with its own history?

The fiscal 2025 figure is higher than in every one of the 17 earlier fiscal years on record, whose median is 10.4%.

What are the highest and lowest return on equity figures on record for Illumina?

Across the 18 fiscal years on record (2008–2025), the highest was 31.2% in fiscal 2025 and the lowest -66.7% in fiscal 2022.

How is Illumina's return on equity calculated?

Return on equity is net income divided by shareholders' equity at the fiscal year-end; it is left blank when equity is negative.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Illumina (ILMN) return on equity (ROE)”, data as of 17 November 2026. https://funkfolio.com/stock/ILMN/roe

Underlying data: the company's filings with the SEC and Yahoo Finance.